145 related articles for article (PubMed ID: 21720831)
1. [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].
Waalkes S; Eggers H; Rustemeier J; Wegener G; Jentzmik F; Schrader M; Hofmann R; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1118-24. PubMed ID: 21720831
[TBL] [Abstract][Full Text] [Related]
2. Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma.
Schrader AJ; Rustemeier J; Rustemeier JC; Timmesfeld N; Varga Z; Hegele A; Olbert PJ; Hofmann R
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1693-9. PubMed ID: 19543914
[TBL] [Abstract][Full Text] [Related]
3. Obesity is associated with improved survival in patients with organ-confined clear-cell kidney cancer.
Waalkes S; Merseburger AS; Kramer MW; Herrmann TR; Wegener G; Rustemeier J; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ
Cancer Causes Control; 2010 Nov; 21(11):1905-10. PubMed ID: 20652393
[TBL] [Abstract][Full Text] [Related]
4. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy.
Haferkamp A; Pritsch M; Bedke J; Wagener N; Pfitzenmaier J; Buse S; Hohenfellner M
BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors.
Kamat AM; Shock RP; Naya Y; Rosser CJ; Slaton JW; Pisters LL
Urology; 2004 Jan; 63(1):46-50. PubMed ID: 14751346
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
7. Urinary collecting system invasion is no independent prognostic factor in renal cell carcinoma.
Waalkes S; Merseburger AS; Herrmann TR; Kramer MW; Wegener G; Rustemeier J; Hofmann R; Kuczyk MA; Schrader AJ
World J Urol; 2010 Jun; 28(3):283-8. PubMed ID: 20237784
[TBL] [Abstract][Full Text] [Related]
8. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.
Parker AS; Lohse CM; Cheville JC; Thiel DD; Leibovich BC; Blute ML
Urology; 2006 Oct; 68(4):741-6. PubMed ID: 17070345
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of body mass index in patients with localized renal cell carcinoma.
Wang C; Chen Z; Dong J; Wen B; Fang Y
Int Braz J Urol; 2018; 44(6):1147-1155. PubMed ID: 30516928
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: A large multicenter retrospective analysis.
Byun SS; Hwang EC; Kang SH; Hong SH; Chung J; Kwon TG; Kim HH; Kwak C; Kim YJ; Lee WK
J Surg Oncol; 2018 Jul; 118(1):199-205. PubMed ID: 29949668
[TBL] [Abstract][Full Text] [Related]
11. [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].
Waalkes S; Roos FC; Eggers H; Schumacher S; Janssen M; Wegener G; Thüroff JW; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1125-9. PubMed ID: 21845424
[TBL] [Abstract][Full Text] [Related]
12. Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Jung EJ; Lee HJ; Kwak C; Ku JH; Moon KC
Urology; 2009 Jan; 73(1):137-41. PubMed ID: 18950844
[TBL] [Abstract][Full Text] [Related]
13. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
14. Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.
Schrader AJ; Rustemeier J; Varga Z; Hegele A; Olbert PJ; Frohme C; Hofmann R
Int J Urol; 2009 Sep; 16(9):718-22. PubMed ID: 19659680
[TBL] [Abstract][Full Text] [Related]
15. Body mass index as independent predictor of overall survival in patients with advanced renal cell carcinoma at start of systemic treatment-Analyses from the German clinical RCC-Registry.
Goebell PJ; Müller L; Hübner A; Harich HD; Boller E; Koska M; Jänicke M; Marschner N;
Urol Oncol; 2018 Oct; 36(10):470.e1-470.e9. PubMed ID: 30131294
[TBL] [Abstract][Full Text] [Related]
16. Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer. Changes of follow-up protocol.
Frank I; Zincke H
Urologe A; 2004 Sep; 43 Suppl 3():S125-8. PubMed ID: 15179551
[No Abstract] [Full Text] [Related]
17. Prognostic Value of Body Mass Index According to Histologic Subtype in Nonmetastatic Renal Cell Carcinoma: A Large Cohort Analysis.
Lee WK; Hong SK; Lee S; Kwak C; Oh JJ; Jeong CW; Kim YJ; Kang SH; Hong SH; Byun SS
Clin Genitourin Cancer; 2015 Oct; 13(5):461-8. PubMed ID: 25990340
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implication of Body Mass Index on Survival Outcomes in Surgically Treated Nonmetastatic Renal Cell Carcinoma: A Single-Institutional Retrospective Analysis of a Large Cohort.
Seon DY; Kwak C; Kim HH; Ku JH; Kim HS
Ann Surg Oncol; 2020 Jul; 27(7):2459-2467. PubMed ID: 32246312
[TBL] [Abstract][Full Text] [Related]
20. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?
Steffens S; Grünwald V; Ringe KI; Seidel C; Eggers H; Schrader M; Wacker F; Kuczyk MA; Schrader AJ
Oncologist; 2011; 16(11):1565-71. PubMed ID: 22020210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
